Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Transcortin (cortisol binding globulin)

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 84449 refers to a laboratory test that measures the levels of transcortin, also known as cortisol binding globulin (CBG), in the blood. Transcortin is a type of alpha globulin protein that plays a crucial role in binding steroid hormones, including cortisol, progesterone, aldosterone, and 11-Deoxycorticosteroid. This binding is essential for the regulation and transport of these hormones throughout the body. Transcortin is synthesized in the liver, and its production is influenced by estrogen levels, which can lead to normal physiological increases during pregnancy. Conversely, decreased levels of transcortin may indicate underlying health issues, particularly liver disorders such as cirrhosis, which can impair the liver's ability to produce this protein. The test is performed by obtaining a blood sample through venipuncture, which is a procedure that can be reported separately. The serum obtained from the blood sample is then analyzed using a method known as radioimmunoassay, a sensitive technique that allows for the precise measurement of hormone levels in the serum.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The transcortin (cortisol binding globulin) test, represented by CPT® Code 84449, is indicated for the evaluation of various clinical conditions related to steroid hormone levels. The following are specific indications for performing this test:

  • Assessment of Hormonal Imbalance - The test is utilized to assess conditions that may involve abnormal levels of steroid hormones, such as cortisol and progesterone.
  • Evaluation of Liver Function - It is indicated in the investigation of liver disorders, particularly when cirrhosis or other hepatic conditions are suspected, as these can affect transcortin production.
  • Monitoring During Pregnancy - The test may be performed to monitor transcortin levels during pregnancy, where normal elevations are expected due to increased estrogen levels.

2. Procedure

The procedure for obtaining the transcortin (cortisol binding globulin) test involves several key steps, which are outlined below:

  • Step 1: Patient Preparation - Prior to the blood draw, the patient may be instructed to follow specific guidelines, such as fasting or avoiding certain medications that could affect hormone levels. However, specific preparation instructions are not detailed in the provided data.
  • Step 2: Venipuncture - A qualified healthcare professional performs venipuncture to obtain a blood sample. This involves inserting a needle into a vein, typically in the arm, to collect the necessary volume of blood for testing. The procedure is performed using sterile techniques to minimize the risk of infection.
  • Step 3: Serum Separation - After the blood sample is collected, it is processed to separate the serum from the cellular components. This is typically done by centrifugation, which spins the sample at high speeds to separate the liquid serum from the blood cells.
  • Step 4: Testing - The serum is then subjected to analysis using radioimmunoassay, a laboratory technique that allows for the quantification of transcortin levels in the serum. This method utilizes radioactively labeled antibodies that specifically bind to transcortin, enabling accurate measurement.

3. Post-Procedure

After the transcortin test is completed, the patient may be monitored briefly to ensure there are no immediate complications from the venipuncture, such as excessive bleeding or discomfort. The results of the test will be analyzed and reported to the healthcare provider, who will interpret the findings in the context of the patient's overall health and any symptoms they may be experiencing. Depending on the results, further testing or follow-up may be necessary to address any identified hormonal imbalances or liver function issues.

Short Descr ASSAY OF TRANSCORTIN
Medium Descr ASSAY OF TRANSCORTIN CORTISOL BINDING GLOBULIN
Long Descr Transcortin (cortisol binding globulin)
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
GA Waiver of liability statement issued as required by payer policy, individual case
Date
Action
Notes
2013-01-01 Changed Medium Descriptor changed.
1994-01-01 Added First appearance in code book in 1994.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"